Dr. Attila Balogh is an Associate Professor at the Department of Automation and Applied Informatics within the Budapest University of Technology and Economics . His work focuses on advanced pharmaceutical technologies, particularly electrospinning for drug delivery systems. He has contributed to scalable manufacturing methods for solid dispersions and dissolution enhancement techniques. Research spans electrospinning, melt extrusion, and 3D printing for pharmaceutical applications Key areas include stability of amorphous drugs, biopharmaceutical modeling, and nanoparticle/nanofiber formulation Publications highlight collaborations between materials science and drug delivery optimization Contact: Budapest 1117, Magyar tudósok krt. 2., Balogh.Attila@aut.bme.hu
Oladiran Oluwafemi Fasina serves as Professor and Department Head of Biosystems Engineering within Auburn University's College of Engineering, demonstrating leadership in sustainable engineering solutions for food systems and bioenergy. His strategic direction has positioned the department at the forefront of agricultural and biological engineering innovation, as evidenced by Auburn's dominance at the 2024 ASABE International Meeting. Education: Ph.D. in Agricultural and Bioresource Engineering from the University of Saskatchewan M.S. in Agricultural Engineering from Obafemi Awolowo University B.S. in Agricultural Engineering from Obafemi Awolowo University Research Focus: Dr. Fasina's expertise spans Biological Materials Preparation and Processing, Food Engineering, Postharvest Technology, and Renewable Energy. His work integrates material science with engineering principles to develop sustainable technologies for biomass conversion, food preservation, and energy production, with particular emphasis on loblolly pine residues and agricultural byproducts. Publication Trends: Analysis of his 15 most recent publications reveals two convergent research trajectories: (1) Advanced drug delivery systems utilizing 3D printing, microneedles, and biodegradable polymers for ocular and implantable applications, and (2) Engineering solutions for biomass logistics, thermochemical conversion, and precision agriculture systems. These streams demonstrate his unique ability to bridge biomedical innovation with sustainable resource management. Research Leadership: Dr. Fasina directs a $2 million Department of Energy grant for hydrogen production from blended feedstocks (waste coal, forest residues, municipal solid waste) and co-leads a $28 million USDA NIFA grant establishing the Institute for Rural Partnership. His interdisciplinary team also investigates hydrogen energy production to reduce greenhouse gas emissions and address plastic waste challenges. Laboratory Infrastructure: His research program encompasses facilities for biomass characterization, material processing, and pharmaceutical engineering, supporting collaborative work across engineering disciplines to develop practical solutions for food security, renewable energy, and healthcare delivery systems.
Ecevit Bilgili is a Professor in the Department of Chemical and Materials Engineering at New Jersey Institute of Technology (NJIT). His research focuses on particulate processes, pharmaceutical engineering, and materials science, with a strong emphasis on drug delivery systems, nanoparticle stabilization, and process optimization. He has authored over 125 publications and holds an h-index of 35, with 3,827 citations. His work spans topics such as wet media milling for drug nanosuspensions, nonlinear breakage kinetics in milling processes, and the development of robust drug delivery platforms like polymer strip films. Bilgili has secured federal grants, including a 2022 grant supporting his research. His contributions include advancing understanding of particle breakage mechanisms, pharmaceutical process engineering, and material recycling techniques. Collaborations with industry and academic partners have led to innovations in drug formulation, including fast-dissolving nanocomposite drug powders and surfactant-free delivery systems. His research also extends to polymer mechanics, particularly the behavior of vulcanized rubbers under complex deformation conditions. Key achievements include pioneering studies on the Rehbinder effect in continuous nanoparticle production, the role of stabilizers in nanosuspensions, and the application of discrete element methods for breakage rate modeling. His work bridges fundamental science and industrial applications, addressing challenges in pharmaceutical manufacturing, materials recycling, and sustainable processing technologies.
Ecevit Bilgili is a Professor in the Department of Chemical and Materials Engineering at New Jersey Institute of Technology (NJIT). His research focuses on pharmaceutical engineering, nanoparticle technology, and process intensification with applications in drug delivery systems. He has authored over 125 publications and holds an h-index of 35. Key research areas include: development of drug nanosuspensions, optimization of milling processes for nanoparticle production, stabilization mechanisms for pharmaceutical formulations, and novel drug delivery systems using polymer films and nanocomposites. Notable contributions include studies on breakage kinetics in media milling, surfactant-free drug delivery platforms, and the application of advanced analytical techniques like Raman spectroscopy for formulation monitoring. His work bridges chemical engineering principles with pharmaceutical manufacturing challenges. He has secured federal grants supporting his research and has extensive collaboration with industry partners in pharmaceutical development. Active in peer review and conference organizing, he contributes to advancing pharmaceutical powder technology understanding.
Dr. Hasham Shafi is a Postdoctoral Associate in the Mansour Lab at Florida International University (FIU). His research focuses on overcoming drug resistance in tuberculosis (TB) through targeted drug delivery systems and host-directed therapies. He holds a Ph.D. in Pharmaceutics from the CSIR-Central Drug Research Institute and the University of Kashmir, India, with prior experience as a Research Fellow in nanotechnology and pharmaceutics. Dr. Shafi’s expertise includes formulation development (e.g., dry powder inhalations, fast-dissolving systems), analytical methods, and preclinical studies in biomedicine. His work spans drug delivery systems for antibiotics, nanofiber fabrication, and biomaterials engineering. He has contributed to studies on mycobacterial biofilms, phage therapy, and modulating host immune responses to combat drug resistance. His recent articles emphasize innovations in drug delivery mechanisms for TB treatment, biomaterials for tissue engineering, and preclinical pharmacokinetic studies. His research integrates interdisciplinary approaches to address unmet needs in antimicrobial therapies and targeted drug delivery.
